---
title: "PharmaCyte Biotech, Inc. (PMCB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PMCB.US.md"
symbol: "PMCB.US"
name: "PharmaCyte Biotech, Inc."
industry: "Biotechnology"
---

# PharmaCyte Biotech, Inc. (PMCB.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [armacyte.com](https://armacyte.com) |

## Company Profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based li...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.93 | 177/602 | 142.17 | 0.83 | 0.70 |
| PB | 0.20 | 8/602 | 0.22 | 0.18 | 0.15 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/PMCB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PMCB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PMCB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.